[The efficiency and cost-utility ratio of interferon beta in the treatment of multiple sclerosis in Andalusia].

Abstract

INTRODUCTION The availability of the interferon beta in its three forms at the moment available in our country and of glatiramer acetate has marked a point of flexion in the natural history of multiple sclerosis (MS), but the high cost of these treatments cause that its use is questioned. In this work we have studied the effectiveness and efficiency of the… (More)

Topics

  • Presentations referencing similar topics